Paediatric sickle cell disease: Pulmonary hypertension but normal vascular resistance

Archives of Disease in Childhood

Volumn 96, Issue 2, 2011, Pages 131-136

  Chaudry, Rifat A ^a,b   Cikes, Maja ^a   Karu, Tiia ^a   Hutchinson, Carmel ^a   Ball, Sarah ^a   Sutherland, George ^a   Rosenthal, Mark ^b   Bush, Andrew ^b   Crowley, Suzanne ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEART OUTPUT; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART STROKE VOLUME; HUMAN; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCHOOL CHILD; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; CHILD; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; OXYGEN; PROSPECTIVE STUDIES; STROKE VOLUME; TRICUSPID VALVE INSUFFICIENCY; VASCULAR RESISTANCE;

EID: 78651467236     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.184028     Document Type: Article

References (43)

1. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004 ; 350 : 886-95.
2. Darbari DS, Kple-Faget P, Kwagyan J, et al. Circumstances of death in adult sickle cell disease patients. Am J Hematol 2006 ; 81 : 858-63.
3. Manci EA, Culberson DE, Yang YM, et al. Causes of death in sickle cell disease: an autopsy study. Br J Haematol 2003 ; 123 : 359-65.
4. Graham JK, Mosunjac M, Hanzlick RL, et al. Sickle cell lung disease and sudden death: a retrospective/prospective study of 21 autopsy cases and literature review. Am J Forensic Med Pathol 2007 ; 28 : 168-72.
5. Castro O, Hoque M, Brown BD. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood 2003 ; 101 : 1257-61.
6. Kato GJ, Onyekwere OC, Gladwin MT. Pulmonary hypertension in sickle cell disease: relevance to children. Pediatr Hematol Oncol 2007 ; 24 : 159-70.
7. De Castro LM, Jonassaint JC, Graham FL, et al. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol 2008 ; 83 : 19-25.
8. Gordeuk VR, Sachdev V, Taylor JG, et al. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insuffi ciency. Am J Hematol 2008 ; 83 : 15-18.
9. Ataga KI, Sood N, De Gent G, et al. Pulmonary hypertension in sickle cell disease. Am J Med 2004 ; 117 : 665-9.
10. Suell MN, Bezold LI, Okcu MF, et al. Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol 2005 ; 27 : 654-8.
11. Ambrusko SJ, Gunawardena S, Sakara A, et al. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatr Blood Cancer 2006 ; 47 : 907-13.
12. Qureshi N, Joyce JJ, Qi N, et al. Right ventricular abnormalities in sickle cell anemia: evidence of a progressive increase in pulmonary vascular resistance. J Pediatr 2006 ; 149 : 23-7.
13. Nelson SC, Adade BB, McDonough EA, et al. High prevalence of pulmonary hypertension in children with sickle cell disease. J Pediatr Hematol Oncol 2007 ; 29 : 334-7.
14. Pashankar FD, Carbonella J, Bazzy-Asaad A, et al. Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease. Br J Haematol 2009 ; 144 : 736-41.
15. Liem RI, Nevin MA, Prestridge A, et al. Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease. Pediatr Pulmonol 2009 ; 44 : 281-9.
16. Sedrak A, Rao SP, Miller ST, et al. A prospective appraisal of pulmonary hypertension in children with sickle cell disease. J Pediatr Hematol Oncol 2009 ; 31 : 97-100.
17. Caldas M C, Meira ZA, Barbosa MM. Evaluation of 107 patients with sickle cell anemia through tissue Doppler and myocardial performance index. J Am Soc Echocardiogr 2008 ; 21 : 1163-7.
18. Onyekwere OC, Campbell A, Teshome M, et al. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol 2008 ; 29 : 309-12.
19. Hagar RW, Michlitsch JG, Gardner J, et al. Clinical differences between children and adults with pulmonary hypertension and sickle cell disease. Br J Haematol 2008 ; 140 : 104-12.
20. Lee MT, Small T, Khan MA, et al. Doppler-defi ned pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years. Br J Haematol 2009 ; 146 : 437-41.
21. Tanner J M, Davies PS. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985 ; 107 : 317-29.
22. Higgins B G, Douglas JG. The new BTS/SIGN asthma guidelines: where evidence leads the way. Thorax 2003 ; 58 : 98-9.
23. D urkin R J, Evans TW, Winter SM. Noninvasive estimation of pulmonary vascular resistance by stroke index measurement with an inert gas rebreathing technique. Chest 1994 ; 106 : 59-66.
24. Oh JK , Seward J, Tajik A. The echo manual . (fi rst edition). Boston, Massachusetts: Little, Brown and Company, 1994:51-8.
25. Schannwell CM, Steiner S, Strauer BE. Diagnostics in pulmonary hypertension. J Physiol Pharmacol 2007 ; 58 : 591-602.
26. Rajagopalan N , Simon MA, Suffoletto MS, et al. Noninvasive estimation of pulmonary vascular resistance in pulmonary hypertension. Echocardiography 2009 ; 26 : 489-94.
27. A bbas A E, Fortuin FD, Schiller NB, e t al. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 2003 ; 41 : 1021-7.
28. Farhi L E, Nesarajah MS, Olszowka AJ, e t al. C ardiac output determination by simple one-step rebreathing technique. Respir Physiol 1976 ; 28 : 141-59.
29. Rosenthal M, Bush A. Haemodynamics in children during rest and exercise: methods and normal values. Eur Respir J 1998 ; 11 : 854-65.
30. Hoeper MM, Maier R, Tongers J, et al. Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 1999 ; 160 : 535-41.
31. N arang I , Rosenthal M, Bush A. Reproducibility of cardioventilatory measurements using a respiratory mass spectrometer. Respir Physiol Neurobiol 2007 ; 157 : 310-15.
32. Bland J M, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 ; 1 : 307-10.
33. Boucek RJ, Jr, Martinez R. Echocardiographic determination of right ventricular function. Cardiol Young 2005 ; 15 : 48-50.
34. Joyce K , Sable C, Martin B. Pulmonary artery hypertension in children with sickle cell disease: is chronic transfusion protective? Blood 2006 ; 108 : 356 (abstract).
35. Minniti CP, Sable C, Campbell A, et al. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica 2009 ; 94 : 340-7.
36. Roy SB, Bhatia ML, Mathur VS, et al. Hemodynamic effects of chronic severe anemia. Circulation 1963 ; 28 : 346-56.
37. Batra A S, Acherman RJ, Wong WY, et al. C ardiac abnormalities in children with sickle cell anemia. Am J Hematol 2002 ; 70 : 306-12.
38. Dham N, Ensing G, Minniti C, et al. Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease. Am J Cardiol 2009 ; 104 : 713-20.
39. Boyd J H, DeBaun MR, Morgan WJ, e t al. L ower airway obstruction is associated with increased morbidity in children with sickle cell disease. Pediatr Pulmonol 2009 ; 44 : 290-6.
40. Ozbek O Y, Malbora B, Sen N, e t al. A irway hyperreactivity detected by methacholine challenge in children with sickle cell disease. Pediatr Pulmonol 2007 ; 42 : 1187-92.
41. Setty BN, Stuart MJ, Dampier C, et al. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet 2003 ; 362 : 1450-5.
42. K ato G J, McGowan V, Machado RF, e t al. L actate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006 ; 107 : 2279-85.
43. H yduk A , Croft JB, Ayala C, e t al. Pulmonary hypertension surveillance-United States, 1980-2002. MMWR Surveill Summ 2005 ; 54 : 1-28.